Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility

被引:89
作者
Xia, Mingxuan
Land, Hartmut
机构
[1] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA
[2] Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Rochester, NY 14642 USA
关键词
D O I
10.1038/nsmb1208
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many features of the cancer cell phenotype emerge as a result of cooperation between multiple oncogenic mutations. Here we show that activated Ras(V12) and loss of p53 function can cooperate to promote cell motility, a feature closely associated with cancer progression to malignancy. Our analysis indicates that Ras(V12) and loss of p53 synergistically induce RhoA activity, revealing a previously unknown role for p53 in tumor suppression. p53 prevents activation of RhoA and thus induction of cell motility by Ras(V12) through a simple signaling circuit, which integrates multiple inputs that converge on RhoA. Our data suggest that p53 suppresses cancer progression to malignancy by modulating the quality of Ras signaling.
引用
收藏
页码:215 / 223
页数:9
相关论文
共 65 条
[1]  
ALBINI A, 1987, CANCER RES, V47, P3239
[2]   MOLECULAR AND CELLULAR ANALYSIS OF BASEMENT-MEMBRANE INVASION BY HUMAN BREAST-CANCER CELLS IN MATRIGEL-BASED INVITRO ASSAYS [J].
BAE, SN ;
ARAND, G ;
AZZAM, H ;
PAVASANT, P ;
TORRI, J ;
FRANDSEN, TL ;
THOMPSON, EW .
BREAST CANCER RESEARCH AND TREATMENT, 1993, 24 (03) :241-255
[3]   p190 RhoGAP is the principal Src substrate in brain and regulates axon outgrowth, guidance and fasciculation [J].
Brouns, MR ;
Matheson, SF ;
Settleman, J .
NATURE CELL BIOLOGY, 2001, 3 (04) :361-367
[4]   Stable suppression of tumorigenicity by virus-mediated RNA interference [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
CANCER CELL, 2002, 2 (03) :243-247
[5]   A system for stable expression of short interfering RNAs in mammalian cells [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
SCIENCE, 2002, 296 (5567) :550-553
[6]   Requirement for p53 and p21 to sustain G2 arrest after DNA damage [J].
Bunz, F ;
Dutriaux, A ;
Lengauer, C ;
Waldman, T ;
Zhou, S ;
Brown, JP ;
Sedivy, JM ;
Kinzler, KW ;
Vogelstein, B .
SCIENCE, 1998, 282 (5393) :1497-1501
[7]   Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer [J].
Burri, N ;
Shaw, P ;
Bouzourene, H ;
Sordat, I ;
Sordat, B ;
Gillet, M ;
Schorderet, D ;
Bosman, FT ;
Chaubert, P .
LABORATORY INVESTIGATION, 2001, 81 (02) :217-229
[8]   Rho and Rac take center stage [J].
Burridge, K ;
Wennerberg, K .
CELL, 2004, 116 (02) :167-179
[9]   Oncogenic Ras and its role in tumor cell invasion and metastasis [J].
Campbell, PM ;
Der, CJ .
SEMINARS IN CANCER BIOLOGY, 2004, 14 (02) :105-114
[10]   The low Mr protein-tyrosine phosphatase is involved in Rho-mediated cytoskeleton rearrangement after integrin and platelet-derived growth factor stimulation [J].
Chiarugi, P ;
Cirri, P ;
Taddei, L ;
Giannoni, E ;
Camici, G ;
Manao, G ;
Raugei, G ;
Ramponi, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (07) :4640-4646